NO20042621L - Sulfonamidosubstituerte imidazopyridiner - Google Patents

Sulfonamidosubstituerte imidazopyridiner

Info

Publication number: NO20042621L
Authority: NO; Norway
Prior art keywords: sulfonamidosubstituted; imidazopyridines; compounds; biosynthesis; induce
Prior art date: 2001-12-06

Application number

NO20042621A

Other languages

English (en)

Norwegian (no)

Inventor

Kyle J Lindstrom

Philip D Heppner

Bryon A Merrill

Jr Joseph F Dellaria

Chad A Haraldson

Original Assignee

3M Innovative Properties Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-12-06

Filing date

2004-06-22

Publication date

2004-06-22

2004-06-22 Application filed by 3M Innovative Properties Co filed Critical 3M Innovative Properties Co

2004-06-22 Publication of NO20042621L publication Critical patent/NO20042621L/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Health & Medical Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Virology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Pulmonology (AREA)
Immunology (AREA)
Molecular Biology (AREA)
Dermatology (AREA)
Hematology (AREA)
Tropical Medicine & Parasitology (AREA)
Neurosurgery (AREA)
Diabetes (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
AIDS & HIV (AREA)
Ophthalmology & Optometry (AREA)
Gastroenterology & Hepatology (AREA)
Biotechnology (AREA)
Otolaryngology (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

NO20042621A 2001-12-06 2004-06-22 Sulfonamidosubstituerte imidazopyridiner NO20042621L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US10/016,073 US20020107262A1 (en)	2000-12-08	2001-12-06	Substituted imidazopyridines
PCT/US2002/018220 WO2003050117A1 (fr)	2001-12-06	2002-06-07	Imidazopyridines a substitution sulfonamide

Publications (1)

Publication Number	Publication Date
NO20042621L true NO20042621L (no)	2004-06-22

Family

ID=21775232

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
NO20042621A NO20042621L (no)	2001-12-06	2004-06-22	Sulfonamidosubstituerte imidazopyridiner
NO20042661A NO20042661L (no)	2001-12-06	2004-06-24	Ureasubstituerte imidazopyridiner
NO20042755A NO20042755L (no)	2001-12-06	2004-06-29	Amidsubstituerte imidazopyridiner

Family Applications After (2)

Application Number	Title	Priority Date	Filing Date
NO20042661A NO20042661L (no)	2001-12-06	2004-06-24	Ureasubstituerte imidazopyridiner
NO20042755A NO20042755L (no)	2001-12-06	2004-06-29	Amidsubstituerte imidazopyridiner

Country Status (18)

Country	Link
US (1)	US20020107262A1 (fr)
EP (3)	EP1451186A2 (fr)
JP (3)	JP2005511746A (fr)
KR (3)	KR20040105696A (fr)
CN (4)	CN100402528C (fr)
AU (3)	AU2002345615B2 (fr)
BR (3)	BR0214749A (fr)
CA (3)	CA2468164A1 (fr)
HR (3)	HRP20040504A2 (fr)
IL (3)	IL161945A0 (fr)
MX (3)	MXPA04005412A (fr)
NO (3)	NO20042621L (fr)
NZ (3)	NZ532926A (fr)
PL (3)	PL374260A1 (fr)
RU (3)	RU2004117156A (fr)
UA (3)	UA77711C2 (fr)
WO (3)	WO2003050117A1 (fr)
ZA (3)	ZA200405334B (fr)

Families Citing this family (80)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6797718B2 (en)	2002-06-07	2004-09-28	3M Innovative Properties Company	Ether substituted imidazopyridines
CN102558155A (zh)	2003-01-14	2012-07-11	阿伦纳药品公司	作为代谢调节剂的芳基和杂芳基衍生物及其所涉及的疾病如糖尿病和高血糖症的预防和治疗
US20040265351A1 (en)	2003-04-10	2004-12-30	Miller Richard L.	Methods and compositions for enhancing immune response
EP1617871A4 (fr) *	2003-04-10	2010-10-06	3M Innovative Properties Co	Distribution de composes modifiant une reponse immunitaire au moyen de materiaux de support particulaires contenant du metal
AR045047A1 (es)	2003-07-11	2005-10-12	Arena Pharm Inc	Derivados arilo y heteroarilo trisustituidos como moduladores del metabolismo y de la profilaxis y tratamiento de desordenes relacionados con los mismos
US7648997B2 (en) *	2003-08-12	2010-01-19	Coley Pharmaceutical Group, Inc.	Hydroxylamine substituted imidazoquinolines
PL1653959T3 (pl) *	2003-08-14	2015-10-30	3M Innovative Properties Co	Modyfikatory odpowiedzi immunologicznej modyfikowane lipidami
EP1658076B1 (fr)	2003-08-27	2013-03-06	3M Innovative Properties Company	Imidazoquinolines substituees par aryloxy et arylalkyleneoxy
EP1660026A4 (fr)	2003-09-05	2008-07-16	3M Innovative Properties Co	Traitement pour le lymphome a cellules b cd5+
NZ546273A (en)	2003-10-03	2009-05-31	Coley Pharm Group Inc	Alkoxy substituted imidazoquinolines
AR046172A1 (es)	2003-10-03	2005-11-30	3M Innovative Properties Co	Pirazolopiridinas y sus analogos; composiciones farmaceuticas que los contienen y su uso en la inhibicion de la biosintesis de citocinas
US7544697B2 (en)	2003-10-03	2009-06-09	Coley Pharmaceutical Group, Inc.	Pyrazolopyridines and analogs thereof
EP1678137A1 (fr) *	2003-10-15	2006-07-12	Chiron Corporation	Compositions et procedes d inhibition virale
AU2004291101A1 (en) *	2003-11-14	2005-06-02	3M Innovative Properties Company	Oxime substituted imidazo ring compounds
CA2545825A1 (fr)	2003-11-14	2005-06-02	3M Innovative Properties Company	Composes d'un anneau d'imidazo substitue par hydroxylamine
EP1686992A4 (fr) *	2003-11-25	2009-11-04	3M Innovative Properties Co	Hydroxylamine, et imidazoquinoleines, et imidazopyridines et imidazonaphtyridine substitues d'oxime
AR046781A1 (es)	2003-11-25	2005-12-21	3M Innovative Properties Co	Derivados de imidazoquinolinas. composiciones farmaceuticas.
AR048289A1 (es) *	2003-12-04	2006-04-19	3M Innovative Properties Co	Eteres de anillos imidazo sulfona sustituidos.
EP1701955A1 (fr)	2003-12-29	2006-09-20	3M Innovative Properties Company	Imidazoquinolines a substitution arylalcenyle et arylalkynyle
AU2004312510A1 (en) *	2003-12-29	2005-07-21	3M Innovative Properties Company	Piperazine, [1,4]diazepane, [1,4]diazocane, and [1,5]diazocane fused imidazo ring compounds
WO2005066169A2 (fr)	2003-12-30	2005-07-21	3M Innovative Properties Company	Sulfonamides d'imidazoquinolinyle, d'imidazopyridinyle et d'imidazonaphtyridinyle
EP1730143A2 (fr)	2004-03-24	2006-12-13	3M Innovative Properties Company	Imidazopyridines, imidazoquinolines, et imidazonaphthyridines a substitution amide
WO2005123079A2 (fr) *	2004-06-14	2005-12-29	3M Innovative Properties Company	Imidazopyridines, imidazoquinolines et imidazonaphthyridines a substitution uree
WO2005123080A2 (fr)	2004-06-15	2005-12-29	3M Innovative Properties Company	Imidazoquinolines et imidazonaphthyridines substituees par un heterocyclyle contenant un azote
US8541438B2 (en)	2004-06-18	2013-09-24	3M Innovative Properties Company	Substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines
AU2005283085B2 (en) *	2004-06-18	2012-06-21	3M Innovative Properties Company	Substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines
US7915281B2 (en)	2004-06-18	2011-03-29	3M Innovative Properties Company	Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and method
WO2006009826A1 (fr)	2004-06-18	2006-01-26	3M Innovative Properties Company	Thiazoloquinolines et thiazolonaphtyridines substitues par aryloxy et arylalkyleneoxy
US7897609B2 (en)	2004-06-18	2011-03-01	3M Innovative Properties Company	Aryl substituted imidazonaphthyridines
WO2006028962A2 (fr) *	2004-09-02	2006-03-16	3M Innovative Properties Company	Systemes cycliques 1-alcoxy 1h-imidazo et procedes associes
CA2578975A1 (fr)	2004-09-02	2006-03-16	3M Innovative Properties Company	Systemes cycliques de 2-amino 1h imidazo et procedes correspondants
EP1804583A4 (fr) *	2004-10-08	2009-05-20	3M Innovative Properties Co	Adjuvant pour vaccin a adn
CA2592904C (fr)	2004-12-30	2015-04-07	3M Innovative Properties Company	Composes chiraux a cycle [1,2]imidazo[4,5] fusionne
US8034938B2 (en)	2004-12-30	2011-10-11	3M Innovative Properties Company	Substituted chiral fused [1,2]imidazo[4,5-c] ring compounds
PL1830876T3 (pl) *	2004-12-30	2015-09-30	Meda Ab	Zastosowanie imikwimodu do leczenia przerzutów do skóry wywodzących się od guza stanowiącego raka piersi
US8436176B2 (en) *	2004-12-30	2013-05-07	Medicis Pharmaceutical Corporation	Process for preparing 2-methyl-1-(2-methylpropyl)-1H-imidazo[4,5-c][1,5]naphthyridin-4-amine
NZ556399A (en) *	2004-12-30	2009-03-31	Takeda Pharmaceutical	1-(2-methylpropyl)-1H-imidazo[4,5-C][1,5]naphthyridin-4-amine ethanesulfonate and 1-(2-methylpropyl)-1H-imidazo[4,5-C][1,5]naphthyridin-4-amine methanesulfonate
AU2006210392A1 (en)	2005-02-04	2006-08-10	Coley Pharmaceutical Group, Inc.	Aqueous gel formulations containing immune response modifiers
JP2008530252A (ja)	2005-02-09	2008-08-07	コーリーファーマシューティカルグループ，インコーポレイテッド	オキシムおよびヒドロキシルアミンで置換されたチアゾロ［４，５−ｃ］環化合物ならびに方法
ES2475728T3 (es)	2005-02-09	2014-07-11	3M Innovative Properties Company	Tiazoloquinolinas y tiazolonaftiridinas sustituidas con alcoxi
US8658666B2 (en)	2005-02-11	2014-02-25	3M Innovative Properties Company	Substituted imidazoquinolines and imidazonaphthyridines
CA2597587A1 (fr)	2005-02-11	2006-08-17	Coley Pharmaceutical Group, Inc.	Composes cycliques imidazo[4,5-c] substitues par oxime et hydroxylamine et procedes associes
AU2006223634A1 (en)	2005-02-23	2006-09-21	Coley Pharmaceutical Group, Inc.	Hydroxyalkyl substituted imidazoquinolines
AU2006216799A1 (en)	2005-02-23	2006-08-31	Coley Pharmaceutical Group, Inc.	Hydroxyalkyl substituted imidazonaphthyridines
US8846710B2 (en)	2005-02-23	2014-09-30	3M Innovative Properties Company	Method of preferentially inducing the biosynthesis of interferon
WO2006091567A2 (fr)	2005-02-23	2006-08-31	Coley Pharmaceutical Group, Inc.	Composes d'imidazoquinolines a substitution hydroxyalkyle et procedes
WO2006107851A1 (fr)	2005-04-01	2006-10-12	Coley Pharmaceutical Group, Inc.	Composes cycliques 1-pyrazolo[3,4-c] substitues comme modulateurs de la biosynthese de cytokine destines au traitement d'infections virales et de maladies neoplastiques
JP2008535832A (ja)	2005-04-01	2008-09-04	コーリーファーマシューティカルグループ，インコーポレイテッド	ピラゾロピリジン−１，４−ジアミン、およびそのアナログ
CA2605808A1 (fr) *	2005-04-25	2006-11-02	3M Innovative Properties Company	Compositions immunostimulantes
EA200800782A1 (ru)	2005-09-09	2008-08-29	Коли Фармасьютикал Груп, Инк.	ПРОИЗВОДНЫЕ АМИДА И КАРБАМАТА N-{2-[4-АМИНО-2-(ЭТОКСИМЕТИЛ)-1Н-ИМИДАЗОЛО[4,5-c]ХИНОЛИН-1-IL]-1,1-ДИМЕТИЛЭТИЛ}МЕТАНСУЛЬФОНАМИДА И СПОСОБЫ
ZA200803029B (en)	2005-09-09	2009-02-25	Coley Pharm Group Inc	Amide and carbamate derivatives of alkyl substituted /V-[4-(4-amino-1H-imidazo[4,5-c] quinolin-1-yl)butyl] methane-sulfonamides and methods
CN100344325C (zh) *	2005-10-17	2007-10-24	华南师范大学	一种治疗宫颈癌的药物及其制备方法与应用
US8088790B2 (en)	2005-11-04	2012-01-03	3M Innovative Properties Company	Hydroxy and alkoxy substituted 1H-imidazoquinolines and methods
EP3085373A1 (fr)	2006-02-22	2016-10-26	3M Innovative Properties Company	Conjugués de modificateur de réponse immunitaire
US8329721B2 (en)	2006-03-15	2012-12-11	3M Innovative Properties Company	Hydroxy and alkoxy substituted 1H-imidazonaphthyridines and methods
US7906506B2 (en)	2006-07-12	2011-03-15	3M Innovative Properties Company	Substituted chiral fused [1,2] imidazo [4,5-c] ring compounds and methods
KR20090063220A (ko) *	2006-08-24	2009-06-17	오스트레일리언뉴클리어사이언스앤드테크놀로지오거나이제이션	말초 벤조디아제핀 수용체를 표적화하기 위한 플루오르화된리간드
WO2008030511A2 (fr)	2006-09-06	2008-03-13	Coley Pharmaceuticial Group, Inc.	3, 4, 6, 7-tétrahydro-5h-1, 2a, 4a, 8-tétraazacyclopenta[cd]phénalènes substitués
GB0625827D0 (en) *	2006-12-22	2007-02-07	Astex Therapeutics Ltd	New compounds
JP5442449B2 (ja)	2006-12-22	2014-03-12	アステックス、セラピューティックス、リミテッド	新規化合物
US8895745B2 (en)	2006-12-22	2014-11-25	Astex Therapeutics Limited	Bicyclic heterocyclic compounds as FGFR inhibitors
US20080149123A1 (en)	2006-12-22	2008-06-26	Mckay William D	Particulate material dispensing hairbrush with combination bristles
GB0720041D0 (en)	2007-10-12	2007-11-21	Astex Therapeutics Ltd	New Compounds
GB0720038D0 (en)	2007-10-12	2007-11-21	Astex Therapeutics Ltd	New compounds
CN101239978A (zh) *	2008-03-05	2008-08-13	南方医科大学	一种咪唑并吡啶类化合物
GB0810902D0 (en)	2008-06-13	2008-07-23	Astex Therapeutics Ltd	New compounds
GB0906470D0 (en)	2009-04-15	2009-05-20	Astex Therapeutics Ltd	New compounds
GB0906472D0 (en)	2009-04-15	2009-05-20	Astex Therapeutics Ltd	New compounds
WO2011076784A2 (fr) *	2009-12-21	2011-06-30	Institut National De La Sante Et De La Recherche Medicale (Inserm)	Nouveaux inhibiteurs de cyclophilines et leurs utilisations
EP3222621B1 (fr)	2010-08-17	2023-03-08	3M Innovative Properties Company	Composé de modificateur de réponse immunitaire lipidée et son utilisation médicale
EA201390421A1 (ru)	2010-09-22	2013-09-30	Арена Фармасьютикалз, Инк.	Модуляторы рецептора gpr119 и лечение связанных с ним нарушений
US9475804B2 (en)	2011-06-03	2016-10-25	3M Innovative Properties Company	Heterobifunctional linkers with polyethylene glycol segments and immune response modifier conjugates made therefrom
WO2012167081A1 (fr)	2011-06-03	2012-12-06	3M Innovative Properties Company	Hydrazino 1h-imidazoquinoléine-4-amines et conjugués obtenus à partir de celles-ci
WO2015023958A1 (fr) *	2013-08-15	2015-02-19	The University Of Kansas	Agonistes de récepteurs de type toll
EP4445956A3 (fr)	2015-01-06	2024-12-04	Arena Pharmaceuticals, Inc.	Composé pour le traitement des affections associés à s1p1-récepteur
PL3310760T3 (pl)	2015-06-22	2023-03-06	Arena Pharmaceuticals, Inc.	Krystaliczna sól L-argininy kwasu (R)-2-(7-(4-cyklopentylo-3-(trifluorometylo)benzyloksy)- 1,2,3,4-tetrahydrocyklo-penta[b]indol-3-ilo)octowego do zastosowania w zaburzeniach związanych z receptorem S1P1
WO2018107173A1 (fr) *	2016-12-09	2018-06-14	Vanderbilt University	Inhibiteurs de transport de glutamine et procédés de traitement du cancer
CN110520124A (zh)	2017-02-16	2019-11-29	艾尼纳制药公司	用于治疗原发性胆汁性胆管炎的化合物和方法
CN111511740B (zh)	2017-12-20	2023-05-16	3M创新有限公司	用作免疫应答调节剂的带有支链连接基团的酰胺取代的咪唑并[4,5-c]喹啉化合物
CA3102136A1 (fr)	2018-06-06	2019-12-12	Arena Pharmaceuticals, Inc.	Methodes de traitement de troubles associes au recepteur s1p1<sb />

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1995002597A1 (fr) *	1993-07-15	1995-01-26	Minnesota Mining And Manufacturing Company	IMIDAZO[4,5-c]PYRIDIN-4-AMINES
AU724042B2 (en) *	1996-10-25	2000-09-07	Minnesota Mining And Manufacturing Company	Immune response modifier compounds for treatment of TH2 mediated and related diseases
US6541485B1 (en) *	1999-06-10	2003-04-01	3M Innovative Properties Company	Urea substituted imidazoquinolines
US6331539B1 (en) *	1999-06-10	2001-12-18	3M Innovative Properties Company	Sulfonamide and sulfamide substituted imidazoquinolines
US6451810B1 (en) *	1999-06-10	2002-09-17	3M Innovative Properties Company	Amide substituted imidazoquinolines
US6376669B1 (en) *	1999-11-05	2002-04-23	3M Innovative Properties Company	Dye labeled imidazoquinoline compounds
UA74593C2 (en) *	2000-12-08	2006-01-16	3M Innovative Properties Co	Substituted imidazopyridines

2001
- 2001-12-06 US US10/016,073 patent/US20020107262A1/en not_active Abandoned
2002
- 2002-06-07 WO PCT/US2002/018220 patent/WO2003050117A1/fr not_active Ceased
- 2002-06-07 IL IL16194502A patent/IL161945A0/xx unknown
- 2002-06-07 AU AU2002345615A patent/AU2002345615B2/en not_active Expired - Fee Related
- 2002-06-07 PL PL02374260A patent/PL374260A1/xx not_active Application Discontinuation
- 2002-06-07 JP JP2003551143A patent/JP2005511746A/ja active Pending
- 2002-06-07 EP EP02741939A patent/EP1451186A2/fr not_active Withdrawn
- 2002-06-07 IL IL16178702A patent/IL161787A0/xx unknown
- 2002-06-07 IL IL16194602A patent/IL161946A0/xx unknown
- 2002-06-07 HR HRP20040504 patent/HRP20040504A2/hr not_active Application Discontinuation
- 2002-06-07 BR BR0214749-1A patent/BR0214749A/pt not_active IP Right Cessation
- 2002-06-07 JP JP2003551141A patent/JP2005513052A/ja active Pending
- 2002-06-07 JP JP2003551142A patent/JP2005511745A/ja active Pending
- 2002-06-07 RU RU2004117156/04A patent/RU2004117156A/ru not_active Application Discontinuation
- 2002-06-07 HR HRP20040506 patent/HRP20040506A2/hr not_active Application Discontinuation
- 2002-06-07 NZ NZ532926A patent/NZ532926A/en unknown
- 2002-06-07 AU AU2002312414A patent/AU2002312414B2/en not_active Expired - Fee Related
- 2002-06-07 KR KR10-2004-7008686A patent/KR20040105696A/ko not_active Ceased
- 2002-06-07 MX MXPA04005412A patent/MXPA04005412A/es not_active Application Discontinuation
- 2002-06-07 CN CNB028242858A patent/CN100402528C/zh not_active Expired - Fee Related
- 2002-06-07 RU RU2004117161/04A patent/RU2004117161A/ru not_active Application Discontinuation
- 2002-06-07 EP EP02739783A patent/EP1453829A1/fr not_active Withdrawn
- 2002-06-07 CN CNA2008100030374A patent/CN101220028A/zh active Pending
- 2002-06-07 PL PL02370702A patent/PL370702A1/xx not_active Application Discontinuation
- 2002-06-07 CN CNB028242866A patent/CN100372846C/zh not_active Expired - Fee Related
- 2002-06-07 NZ NZ532770A patent/NZ532770A/en unknown
- 2002-06-07 EP EP02744260A patent/EP1451187A1/fr not_active Withdrawn
- 2002-06-07 CN CNB028242874A patent/CN100387597C/zh not_active Expired - Fee Related
- 2002-06-07 MX MXPA04005331A patent/MXPA04005331A/es unknown
- 2002-06-07 WO PCT/US2002/018284 patent/WO2003050119A2/fr not_active Ceased
- 2002-06-07 KR KR10-2004-7008644A patent/KR20040105694A/ko not_active Ceased
- 2002-06-07 HR HRP20040503 patent/HRP20040503A2/hr not_active Application Discontinuation
- 2002-06-07 MX MXPA04005363A patent/MXPA04005363A/es unknown
- 2002-06-07 CA CA002468164A patent/CA2468164A1/fr not_active Abandoned
- 2002-06-07 AU AU2002315006A patent/AU2002315006B2/en not_active Expired - Fee Related
- 2002-06-07 BR BR0214752-1A patent/BR0214752A/pt not_active IP Right Cessation
- 2002-06-07 CA CA002468659A patent/CA2468659A1/fr not_active Abandoned
- 2002-06-07 WO PCT/US2002/018282 patent/WO2003050118A1/fr not_active Ceased
- 2002-06-07 RU RU2004117159/04A patent/RU2004117159A/ru not_active Application Discontinuation
- 2002-06-07 BR BR0214999-0A patent/BR0214999A/pt not_active IP Right Cessation
- 2002-06-07 PL PL02370738A patent/PL370738A1/xx not_active Application Discontinuation
- 2002-06-07 NZ NZ532927A patent/NZ532927A/en unknown
- 2002-06-07 KR KR10-2004-7008676A patent/KR20040105695A/ko not_active Ceased
- 2002-06-07 CA CA002468174A patent/CA2468174A1/fr not_active Abandoned
- 2002-07-06 UA UA20040604343A patent/UA77711C2/uk unknown
- 2002-07-06 UA UA20040604339A patent/UA77709C2/uk unknown
- 2002-07-06 UA UA20040604342A patent/UA77710C2/uk unknown
2004
- 2004-06-22 NO NO20042621A patent/NO20042621L/no not_active Application Discontinuation
- 2004-06-24 NO NO20042661A patent/NO20042661L/no not_active Application Discontinuation
- 2004-06-29 NO NO20042755A patent/NO20042755L/no not_active Application Discontinuation
- 2004-07-05 ZA ZA200405334A patent/ZA200405334B/en unknown
- 2004-07-05 ZA ZA200405336A patent/ZA200405336B/en unknown
- 2004-07-05 ZA ZA200405337A patent/ZA200405337B/en unknown

Also Published As

Publication number	Publication date
JP2005511745A (ja)	2005-04-28
AU2002345615A1 (en)	2003-06-23
AU2002315006A1 (en)	2003-06-23
EP1451186A2 (fr)	2004-09-01
WO2003050119A2 (fr)	2003-06-19
MXPA04005331A (es)	2004-09-13
AU2002312414A1 (en)	2003-06-23
PL370702A1 (en)	2005-05-30
CN100402528C (zh)	2008-07-16
JP2005511746A (ja)	2005-04-28
ZA200405334B (en)	2006-12-27
CN1599738A (zh)	2005-03-23
CA2468659A1 (fr)	2003-06-19
AU2002345615B2 (en)	2009-01-15
NO20042661L (no)	2004-06-24
RU2004117161A (ru)	2005-05-10
NO20042755L (no)	2004-06-29
MXPA04005363A (es)	2004-09-27
CN1599740A (zh)	2005-03-23
IL161787A0 (en)	2005-11-20
WO2003050118A1 (fr)	2003-06-19
US20020107262A1 (en)	2002-08-08
MXPA04005412A (es)	2004-10-11
CA2468164A1 (fr)	2003-06-19
CN100372846C (zh)	2008-03-05
BR0214752A (pt)	2005-08-02
WO2003050117A1 (fr)	2003-06-19
PL374260A1 (en)	2005-10-03
HRP20040506A2 (en)	2004-12-31
KR20040105694A (ko)	2004-12-16
UA77709C2 (en)	2007-01-15
EP1453829A1 (fr)	2004-09-08
AU2002315006B2 (en)	2009-01-29
PL370738A1 (en)	2005-05-30
UA77710C2 (en)	2007-01-15
CN1599739A (zh)	2005-03-23
UA77711C2 (en)	2007-01-15
KR20040105696A (ko)	2004-12-16
NZ532770A (en)	2006-07-28
CN101220028A (zh)	2008-07-16
ZA200405337B (en)	2006-12-27
HRP20040503A2 (en)	2004-12-31
BR0214749A (pt)	2004-08-31
WO2003050119A3 (fr)	2003-07-10
IL161945A0 (en)	2005-11-20
EP1451187A1 (fr)	2004-09-01
RU2004117156A (ru)	2006-01-10
ZA200405336B (en)	2006-12-27
JP2005513052A (ja)	2005-05-12
RU2004117159A (ru)	2006-01-10
HRP20040504A2 (en)	2004-12-31
AU2002312414B2 (en)	2009-02-19
NZ532926A (en)	2006-06-30
CN100387597C (zh)	2008-05-14
NZ532927A (en)	2006-06-30
CA2468174A1 (fr)	2003-06-19
KR20040105695A (ko)	2004-12-16
IL161946A0 (en)	2005-11-20
BR0214999A (pt)	2004-12-28

Publication	Publication Date	Title
NO20042621L (no)	2004-06-22	Sulfonamidosubstituerte imidazopyridiner
NO20045445L (no)	2005-02-18	Etersubstituerte imidazopyridiner
WO2002046194A3 (fr)	2003-02-06	Imidazopyridines substituees
DK1198233T3 (da)	2006-12-04	Sulfonamid- og sulfamidsubstituerede imidazoquinoliner
TW200514784A (en)	2005-05-01	Sulfonamide substituted imidazoquinolines
NO20070866L (no)	2007-04-13	Antivirale forbindelser.
DE60208385D1 (de)	2006-02-02	Antineoplasische kombinationspräparate
MXPA04005362A (es)	2004-09-27	Imidazoquinolinas sustituidas con tioeter.
WO2002046193A3 (fr)	2003-02-27	Imidazoquinolines substituees ether heterocyclique
DE60205742D1 (de)	2005-09-29	Tartrate des 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaens
DK2128246T3 (da)	2014-05-12	Fremgangsmåder og sammensætninger til fremstilling af ortogonale tRNA-aminoacyl-tRNA-syntetasepar.
DK1443925T3 (da)	2007-03-19	Naphthyridinderivater, deres fremstilling og deres anvendelse som inhibitorer af phosphodiesteraseisoenzym 4 (PDE4)
DK1206474T3 (da)	2004-10-04	Sulfonylphenylpyrazolforbindelser anvendelige som cox-2-inhibitorer
DK1198232T3 (da)	2007-01-02	Urinstofsubstituerede imidazoquinoliner
NO20053600D0 (no)	2005-07-22	Pyrazolo (3,4-b)pyridinforbindelser og anvendelse derav som fosfodiesterase inhibitorer.
IS7202A (is)	2004-03-31	Samsetningar til meðhöndlunar á ónæmisbólgusjúkdómum
ATE312096T1 (de)	2005-12-15	Neue verbindungen
MXPA03006817A (es)	2003-11-13	Metodo de tratamiento de enfermedades inflamatorias e inmunes usando inhibidores de la ikb cinasa (ikk).
TR201910060T4 (tr)	2019-07-22	SYN3 bileşimleri ve yöntemleri.
DK1390364T3 (da)	2004-12-20	Aryl-8-azabicyclo[3.2.1]octaner til behandling af depression
NO20025765L (no)	2003-01-08	Kombinasjonssett for behandling av malaria
DK1453783T3 (da)	2007-01-29	Substituerede arylcycloalkaner og deres anvendelse som anticancermidler
DE10157913B4 (de)	2005-03-10	Therapietisch
ITMI20022141A1 (it)	2004-04-10	Handling sicuro di c4f6 (esafluorobutadiene).
SE0102015D0 (sv)	2001-06-07	The rocking table

Legal Events

Date	Code	Title	Description
2010-01-25	FC2A	Withdrawal, rejection or dismissal of laid open patent application